Conditions: Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 325
Healthy volunteers: no

Brief summary:
The main purpose of this study is to compare the effectiveness of Human Regular U-500 Insulin three times a day versus twice a day.

Detailed description:

Arms:
arm 1: Human Regular U-500 Insulin (U-500R) titrated based on blood glucose readings, administered subcutaneously (SC), three times a day (TID) for 24 weeks. arm 2: U-500R Insulin titrated based on blood glucose readings, administered SC, two times a day (BID) for 24 weeks.

Interventions: intervention 1: Human Regular U-500 Insulin
Intervention descriptions: intervention 1: None

Protocol document: